News Kyung Dong Pharmaceutical Co., Ltd.

Equities

A011040

KR7011040003

End-of-day quote Korea S.E. Other stock markets 03:30:00 14/05/2024 am IST			5-day change	1st Jan Change
6,410 ^KRW	-0.16%		+0.94%	-3.03%

03/05	Tranche Update on Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 30, 2024.	CI
03/05	Tranche Update on Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 30, 2024.	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tranche Update on Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 30, 2024.	03/05	CI
Tranche Update on Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 30, 2024.	03/05	CI
Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback announced on January 30, 2024, has closed with 200,000 shares, representing 0.74% for KRW 1,278.39 million.	26/04	CI
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03	CI
Kyung Dong Pharmaceutical Co., Ltd. announces an Equity Buyback for 200,000 shares.	30/01	CI
Kyung Dong Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	30/01	CI
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
Kyung Dong Pharmaceutical Co., Ltd.(KOSDAQ:A011040) dropped from S&P Global BMI Index	18/23/18	CI
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/23/14	CI
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15	CI
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/22/14	CI
Tranche Update on Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 16, 2022.	20/22/20	CI
Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback announced on September 16, 202, has closed with 100,000 shares, representing 0.37% for KRW 749.64 million.	13/22/13	CI
Kyung Dong Pharmaceutical Co., Ltd. announces an Equity Buyback for 100,000 shares.	16/22/16	CI
Kyung Dong Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	16/22/16	CI
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/22/16	CI
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/22/16	CI
Eight South Korean Firms to Donate $2.4 Million Worth of Medicine to Ukraine	12/22/12	MT
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	21/22/21	CI
Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback announced on August 17, 2021, has expired.	17/21/17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Kyung Dong Pharmaceutical Co., Ltd.

Equities

A011040

KR7011040003

Summary

Filters